Home › Macular Degeneration › Connecticut
Macular Degeneration clinical trials in Connecticut
6 studies for Macular Degeneration are looking for participants at sites in Connecticut.
Cities in Connecticut
A Study in Adults With Geographic Atrophy
- Retina Group of New England, PC, Waterford
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Group of New England, Waterford
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Retina Consultants PC, Manchester
Recruiting
Ages 60 and older · All sexes · Updated Aug 26, 2026 · NCT06662162A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Connecticut Eye Consultants, P.C., Danbury
- Retina Consultants, P.C., Manchester
- Retina Group of New England, Waterford
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Aug 6, 2026 · NCT07496567Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Westport
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT03011541Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
- CBCC Global Research Site:005, Manchester
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Feb 7, 2025 · NCT06132035From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.